Comparisons with previous research suggest that rates of PTSD are higher among women who undergo ABMT as opposed to less intensive forms of breast cancer treatment. These findings are consistent with the view that development of PTSD symptoms is associated with the degree of life threat. The clinical significance of PTSD in this patient population is underscored by findings indicating that greater PTSD symptoms are associated with poorer health-related quality of life.
Summary:outcome. 7 QOL is a multidimensional phenomenon consisting of physical, psychological, and social dimensions, 7 following BMT, an individual's QOL may be affected by As more women are treated with bone marrow transplantation (BMT) for breast cancer, there is growing difficulties in any or all of these areas. QOL following BMT has been examined in several surinterest in quality of life (QOL) following treatment. Although there have been some clinical studies of QOL vey studies. 7,8 However, in some of these studies, QOL was assessed using methods of questionable reliability and valfollowing BMT, this area has received little systematic attention. In particular, it is unclear how QOL for idity, such as open-ended questionnaires, 9 patient interviews, 10 or non-validated QOL instruments developed by women treated with BMT for breast cancer differs from that which might be expected for 'healthy' women of the study authors. 11 In this introduction, only studies which employed standard, validated questionnaires to assess QOL about the same age. To address this issue, we compared QOL reported by women treated with autologous BMT following BMT are briefly reviewed. In a study conducted by Andrykowski and colleagues, 1 for breast cancer with that of a group of women of similar age with no history of cancer. In addition, we exam-QOL was assessed in individuals who were an average of 26 months post-BMT using the Functional Living Indexined the relationship of demographic factors, medical factors, and self-reported symptom prevalence, severity, Cancer (FLIC). 12 Based on mean FLIC scores, the QOL of the BMT survivors was similar to that of a normative samand distress to QOL in post-BMT patients. All participants completed the SF-36 Health Survey developed ple of cancer patients in active chemotherapy treatment. Poorer QOL in BMT survivors was associated with being from the Medical Outcomes Study (SF-36). Post-BMT patients also completed the ECOG Performance Status older (ie above age 30) at the time of BMT. The QOL of 135 individuals who were an average of 47 Rating Scale (PSR) and the Memorial Symptom Assessment Scale (MSAS). Results indicated that, compared months post-BMT was assessed by Baker and colleagues 3 using a measure of life satisfaction (Satisfaction with Life to the women with no cancer history, post-BMT patients reported significantly impaired physical functioning, Domains Scale; SLDS) 13 and a measure of emotional wellbeing (Profile of Mood States; POMS). 14 Based on physical role functioning, general health, vitality, social functioning, and emotional role functioning. Impaired responses to the SLDS, the authors indicated that the BMT survivors reported an 'above average level of satisfaction' QOL following BMT was significantly associated with lower income, a longer time to engraftment, longer hoswith most areas of life but reported some dissatisfaction with physical strength and sexual relations. In addition, the pital stay, poor performance status, and greater symptom prevalence, severity, and d...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.